Industry sponsor
Definium Therapeutics US, Inc.
7 registered trials on this registry, 2 recruiting now. An industry sponsor is running trials with a view to approval and sale.
7
Registered trials
2
Recruiting
4
In Phase 3
2
With results posted
Working on
Substances
Trials
All 7 trials
| Trial | Status | Phase | Substance | Sites |
|---|---|---|---|---|
| A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)NCT07592689 · Definium Therapeutics US, Inc. | Recruiting | Phase 3 | lsd | 30 |
| A Phase 2A Trial of DT402 for Autism Spectrum DisorderNCT07303907 · Definium Therapeutics US, Inc. | Recruiting | Phase 2 | mdma | 1 |
| A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)NCT06809595 · Definium Therapeutics US, Inc. | Active, not recruiting | Phase 3 | lsd | 36 |
| A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge)NCT06941844 · Definium Therapeutics US, Inc. | Active, not recruiting | Phase 3 | lsd | 22 |
| A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage)NCT06741228 · Definium Therapeutics US, Inc. | Active, not recruiting | Phase 3 | lsd | 34 |
| Safety and Efficacy of Low Dose MM120 for ADHD Proof of Concept TrialNCT05200936 · Definium Therapeutics US, Inc. | Completed | Phase 2 | lsd | 2 |
| A Dose-Finding Study of MM120 (LSD D-Tartrate) for the Treatment of Anxiety SymptomsNCT05407064 · Definium Therapeutics US, Inc. | Completed | Phase 2 | lsd | 22 |
Sponsor attribution is the lead sponsor recorded on ClinicalTrials.gov API v2. Collaborators are not counted here. Data build 2026-08-25.